Skip to content
value.today

Colorescience Inc

🇺🇸 Carlsbad, California, USAHealth CareFounded 2013
Total raised
$51 M
6 rounds on record
Latest round
$3 M
Jan 2020
First round on record
May 2013
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Colorescience Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2020$3 MNo. 6$2 to $10 million

Colorescience Inc: Raise no. 6, Jan 2020

Investors in this round

10 investors had bought by the notice of Feb 10, 2020: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Fisher · Executive Officer, Director
  • Stephen Loomis · Executive Officer
  • Theodore Ebel · Executive Officer
  • Adele Oliva · Director
  • Alex Morgan · Director
  • David Olsen · Director
  • Jessica Hou · Director
  • Josh Baltzell · Director
  • Nicky Kinnaird · Director
  • Ty Stiklorius · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Loomis, CFO, COO, Secretary and Treasurer. Source: SEC Form D, newest notice filed Feb 10, 2020. Read the notice at the SEC.

equitySEC
May 2018$4 MNo. 5$2 to $10 million

Colorescience Inc: Raise no. 5, May 2018

Investors in this round

17 investors had bought by the notice of May 23, 2018: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Fisher · Executive Officer, Director
  • Stephen Loomis · Executive Officer
  • Theodore Ebel · Executive Officer
  • Adele Oliva · Director
  • Alex Morgan · Director
  • David Olsen · Director
  • Josh Baltzell · Director
  • Nicky Kinnaird · Director
  • Richard Aldrich · Director
  • Ty Stiklorius · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Loomis, CFO, COO, Secretary and Treasurer. Source: SEC Form D, newest notice filed May 23, 2018. Read the notice at the SEC.

equitySEC
Jul 2017$15 MNo. 4$10 to $50 million

Colorescience Inc: Raise no. 4, Jul 2017

Investors in this round

34 investors had bought by the notice of Jul 20, 2017: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $16 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Fisher · Executive Officer, Director
  • Stephen Loomis · Executive Officer
  • Theodore Ebel · Executive Officer
  • Adele Oliva · Director
  • Josh Baltzell · Director
  • M Bolyard · Director
  • Michelle Dipp, M.D., Ph.D. · Director
  • Nicky Kinnaird · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Theodore Ebel, Chief Business Officer. Source: SEC Form D, newest notice filed Jul 20, 2017. Read the notice at the SEC.

equitySEC
Mar 2017$4 MNo. 3$2 to $10 million

Colorescience Inc: Raise no. 3, Mar 2017

Investors in this round

32 investors had bought by the notice of Mar 27, 2017: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Fisher · Executive Officer, Director
  • Stephen F. Loomis · Executive Officer
  • Theodore F. Ebel · Executive Officer
  • Brian F. Dovey · Director
  • Daniell F. Turner III · Director
  • David F. Hale · Director
  • James Cavanaugh, Ph.D. · Director
  • Josh F. Baltzell · Director
  • M F. Bolyard · Director
  • Nicky F. Kinnaird · Director
  • Richard F. Aldrich · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Loomis, CFO, COO, Secretary and Treasurer. Source: SEC Form D, newest notice filed Mar 27, 2017. Read the notice at the SEC.

equitySEC
Sep 2014$15 MNo. 2$10 to $50 million

Colorescience Inc: Raise no. 2, Sep 2014

Investors in this round

32 investors had bought by the notice of Sep 22, 2014: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Josie O. Juncal-Schwarz · Executive Officer
  • Mary M. Fisher · Executive Officer, Director
  • Stephen P. Loomis · Executive Officer
  • Theodore O. Ebel · Executive Officer
  • Brian H. Dovey · Director
  • David F. Hale · Director
  • George M. Jenkins · Director
  • Howard D. Palefsky · Director
  • James M. Cavanaugh, Ph.D. · Director
  • Josh J. Baltzell · Director
  • Lynelle D. Lynch · Director
  • Richard D. Aldrich · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen P. Loomis, Chief Financial Officer, Secretary and Treasurer. Source: SEC Form D, newest notice filed Sep 22, 2014. Read the notice at the SEC.

equitySEC
May 2013$10 MNo. 1$10 to $50 million

Colorescience Inc: Raise no. 1, May 2013

Investors in this round

53 investors had bought by the notice of May 31, 2013: 53 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David H. Crist · Executive Officer
  • Mary M. Fisher · Executive Officer, Director
  • Theodore H. Ebel · Executive Officer
  • Brian H. Dovey · Director
  • David F. Hale · Director
  • George M. Jenkins · Director
  • Howard D. Palefsky · Director
  • James H. Cavanaugh, Ph.D. · Director
  • Joshua J. Baltzell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Theodore Ebel, Vp, cbo. Source: SEC Form D, newest notice filed May 31, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Colorescience Inc chose not to state its revenue in its newest notice of a funding round (Feb 2020).

    SEC Form D · Feb 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2020

That is all the official record says: Colorescience Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Colorescience Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 53 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Colorescience Inc
NameRoleNamed in
Mary FisherExecutive officerFeb 2020
Stephen LoomisExecutive officerFeb 2020
Theodore EbelExecutive officerFeb 2020
Stephen F. LoomisExecutive officerMar 2017
Theodore F. EbelExecutive officerMar 2017
Josie O. Juncal-SchwarzExecutive officerSep 2014
Mary M. FisherExecutive officerSep 2014
Stephen P. LoomisExecutive officerSep 2014
Theodore O. EbelExecutive officerSep 2014
David H. CristExecutive officerMay 2013
Theodore H. EbelExecutive officerMay 2013
Adele OlivaDirectorFeb 2020
Alex MorganDirectorFeb 2020
David OlsenDirectorFeb 2020
Jessica HouDirectorFeb 2020
Josh BaltzellDirectorFeb 2020
Mary FisherDirectorFeb 2020
Nicky KinnairdDirectorFeb 2020
Ty StikloriusDirectorFeb 2020
Richard AldrichDirectorMay 2018
M BolyardDirectorJul 2017
Michelle Dipp, M.D., Ph.D.DirectorJul 2017
Brian F. DoveyDirectorMar 2017
Daniell F. Turner IIIDirectorMar 2017
David F. HaleDirectorMar 2017
James Cavanaugh, Ph.D.DirectorMar 2017
Josh F. BaltzellDirectorMar 2017
M F. BolyardDirectorMar 2017
Nicky F. KinnairdDirectorMar 2017
Richard F. AldrichDirectorMar 2017
Brian H. DoveyDirectorSep 2014
George M. JenkinsDirectorSep 2014
Howard D. PalefskyDirectorSep 2014
James M. Cavanaugh, Ph.D.DirectorSep 2014
Josh J. BaltzellDirectorSep 2014
Lynelle D. LynchDirectorSep 2014
Mary M. FisherDirectorSep 2014
Richard D. AldrichDirectorSep 2014
James H. Cavanaugh, Ph.D.DirectorMay 2013
Joshua J. BaltzellDirectorMay 2013